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PRISMA-E 2012 Checklist: capturing the experience of review authors
1. Please estimate how many years experience you have in conducting systematic 
reviews
  
2. Please estimate the length of time you have been working in the field of health equity. 
If you do not work inhealth equity, please select "Not applicable"
  













PRISMA-E 2012 Checklist: capturing the experience of review authors
Consider  a  systematic  review  you  are  currently  working  on  or  have  recently  published  and  answer  the  following  
questions  with  that  review  in  mind.  
4. At what stage is your systematic review?
  
5. Which of the categories below does your review best fit into?
6. Did you/Do you plan to use the PRISMA statement to guide your reporting of your 
review?
  






My  review  is  designed  to  assess  effects  of  interventions  targeted  at  disadvantaged  populations
  

My  review  is  designed  to  assess  effects  of  interventions  aimed  at  reducing  social  gradients  across  populations  (eg.  interventions  to  
reduce  the  social  gradient  in  smoking)  

The  intervention/s  in  my  review  are  not  aimed  at  reducing  inequity,  however  it  is  important  to  understand  the  effects  of  the  
intervention/s  on  equity,  either  positively  or  negatively  

My  review  does  not  have  a  major  focus  on  health  equity  (as  defined  by  the  above  categories)
  













I  have  not  heard  of  the  PRISMA  statement
  

PRISMA-E 2012 Checklist: capturing the experience of review authors
Please  answer  the  question  below  with  your  recent  review  in  mind.  
7. Below are the extension items in the PRISMA-­E 2012 checklist. 
 
Please indicate beside each item whether you intend to address (or have already 
addressed) that item in your review.
  
Testing out PRISMA-­E 2012 on your review
*
Yes No Unsure
Title:  Identify  equity  as  a  focus  of  the  review,  if  relevant,  using  the  term  equity   
Structured  Summary:  State  research  question(s)  related  to  health  equity   
Structured  Summary:  Present  results  of  health  equity  analyses  (e.g.  subgroup  analyses  or  meta-­regression)   
Structured  Summary:  Describe  extent  and  limits  of  applicability  to  disadvantaged  populations  of  interest   
Rationale:  Describe  assumptions  about  mechanism(s)  by  which  the  intervention  is  assumed  to  have  an  impact  on  
health  equity
  
Rationale:  Provide  the  logic  model/analytical  framework,  if  done,  to  show  the  pathways  through  which  the  
intervention  is  assumed  to  affect  health  equity  and  how  it  was  developed
  
Objectives:  Describe  how  disadvantage  was  defined  if  used  as  criteria  in  the  review  (e.g.  for  selecting  studies,  
conducting  analyses  or  judging  applicability)
  
Objectives:  State  the  research  questions  being  addressed  with  reference  to  health  equity   
Methods:  Describe  the  rationale  for  including  particular  study  designs  related  to  equity  research  questions   
Methods:  Describe  the  rationale  for  including  the  outcomes  -­  e.g.  how  are  these  relevant  to  reducing  inequity   
Methods:  Describe  information  sources  (e.g.  health,  non-­health,  and  grey  sources)  that  were  searched  that  are  of  
specific  relevance  to  address  the  equity  questions  of  the  review
  
Methods:  Describe  the  broad  search  strategy  and  terms  used  to  address  equity  questions  of  the  review   
Methods:  List  and  define  data  items  related  to  equity  where  such  data  were  sought  (e.g.  using  PROGRESS-­Plus  or  
other  criteria,  context)
  
Methods:  Describe  methods  of  synthesizing  findings  on  health  inequities  (e.g.  presenting  both  relative  and  absolute  
differences  between  groups)
  
Methods:  Describe  methods  of  additional  synthesis  approaches  related  to  equity  questions,  if  done,  indicating  
which  were  pre-­specified
  
Results:  Present  the  population  characteristics  that  relate  to  the  equity  questions  across  the  relevant  PROGRESS-­
Plus  or  other  factors  of  interest
  
Results:  Present  the  results  of  synthesizing  findings  on  inequities   
Results:  Give  the  results  of  additional  synthesis  approaches  related  to  equity  objectives,  if  done   
Conclusions:  Present  extent  and  limits  of  applicability  to  disadvantaged  populations  of  interest  and  describe  the  
evidence  and  logic  underlying  those  judgements
  
Conclusions:  Provide  implications  for  research,  practice  or  policy  related  to  equity  where  relevant  (e.g.  types  of  






PRISMA-E 2012 Checklist: capturing the experience of review authors
This  will  help  us  understand  what  difference  each  item  in  PRISMA-­E  2012  might  make  in  the  way  review  authors  
conduct  reviews  in  general.  In  other  words,  how  helpful  is  it  to  be  reminded  of  each  item  in  a  reporting  checklist?  
  
  
Consider  the  question  below  in  terms  of  your  approach  to  conducting  reviews  in  general,  rather  than  any  specific  
review.  
8. Please consider for each item whether you would usually always address that 
item (regardless of its inclusion in a reporting checklist), or whether you think having it 
in a reporting checklist would be a helpful reminder.
  
Your opinion on the likelihood of the checklist items to change the way you...
*
I  would  always  address  
this  item,  so  a  checklist  
would  make  no  
difference
I  may  sometimes  
address  this  item,  but  a  
checklist  would  help  to  
remind  me
A  checklist  would  make  
it  much  more  likely  for  
me  to  address  this  item
I  do  not  think  this  item  
is  relevant,  so  a  
checklist  would  make  no  
difference
Title:  Identify  equity  as  a  focus  of  the  
review,  if  relevant,  using  the  term  equity
   
Structured  Summary:  State  research  
question(s)  related  to  health  equity
   
Structured  Summary:  Present  results  of  
health  equity  analyses  (e.g.  subgroup  
analyses  or  meta-­regression)
   
Structured  Summary:  Describe  extent  and  
limits  of  applicability  to  disadvantaged  
populations  of  interest
   
Rationale:  Describe  assumptions  about  
mechanism(s)  by  which  the  intervention  is  
assumed  to  have  an  impact  on  health  
equity
   
Rationale:  Provide  the  logic  
model/analytical  framework,  if  done,  to  
show  the  pathways  through  which  the  
intervention  is  assumed  to  affect  health  
equity  and  how  it  was  developed
   
Objectives:  Describe  how  disadvantage  
was  defined  if  used  as  criteria  in  the  
review  (e.g.  for  selecting  studies,  
conducting  analyses  or  judging  
applicability)
   
Objectives:  State  the  research  questions  
being  addressed  with  reference  to  health  
equity
   
Methods:  Describe  the  rationale  for  
including  particular  study  designs  related  
to  equity  research  questions
   
Methods:  Describe  the  rationale  for  
including  the  outcomes  -­  e.g.  how  are  
these  relevant  to  reducing  inequity
   
Methods:  Describe  information  sources  
(e.g.  health,  non-­health,  and  grey  sources)  
that  were  searched  that  are  of  specific  
relevance  to  address  the  equity  questions  
of  the  review
   
PRISMA-E 2012 Checklist: capturing the experience of review authors
Methods:  Describe  the  broad  search  
strategy  and  terms  used  to  address  equity  
questions  of  the  review
   
Methods:  List  and  define  data  items  
related  to  equity  where  such  data  were  
sought  (e.g.  using  PROGRESS-­Plus  or  
other  criteria,  context)
   
Methods:  Describe  methods  of  
synthesizing  findings  on  health  inequities  
(e.g.  presenting  both  relative  and  
absolute  differences  between  groups)
   
Methods:  Describe  methods  of  additional  
synthesis  approaches  related  to  equity  
questions,  if  done,  indicating  which  were  
pre-­specified
   
Results:  Present  the  population  
characteristics  that  relate  to  the  equity  
questions  across  the  relevant  PROGRESS-­
Plus  or  other  factors  of  interest
   
Results:  Present  the  results  of  synthesizing  
findings  on  inequities
   
Results:  Give  the  results  of  additional  
synthesis  approaches  related  to  equity  
objectives,  if  done
   
Conclusions:  Present  extent  and  limits  of  
applicability  to  disadvantaged  
populations  of  interest  and  describe  the  
evidence  and  logic  underlying  those  
judgements
   
Conclusions:  Provide  implications  for  
research,  practice  or  policy  related  to  
equity  where  relevant  (e.g.  types  of  
research  needed  to  address  unanswered  
questions)





PRISMA-E 2012 Checklist: capturing the experience of review authors
Having  now  seen  all  the  new  checklist  items  in  PRISMA-­E  2012,  please  tell  us  what  you  think.  
9. Would you use PRISMA-­E 2012 to assist in reporting equity in your systematic 
reviews?
10. Overall, do you think using PRISMA-­E 2012 would lead you to report (or conduct) 
your review differently?
  
Your thoughts on the overall utility of the PRISMA-­E 2012 checklist
*
*
Yes,  I  would  use  this  checklist  for  every  review
  

Yes,  I  would  consider  using  this  checklist  depending  on  the  focus  of  my  review
  

No,  I  would  not  use  this  checklist  because  I  am  already  aware  of  the  items  to  include  in  reporting  equity  in  my  reviews
  
















No,  because  I  already  include  these  items  in  reporting  my  reviews
  










PRISMA-E 2012 Checklist: capturing the experience of review authors
11. Do you think using PRISMA-­E 2012 in developing your review would improve the 
useability of your review for decisions about equity?
12. Please list any perceived facilitators and advantages for you in using PRISMA-­E 
2012 to guide reporting on equity in your reviews?
  
13. Please list any potential barriers for you in using PRISMA-­E 2012 to guide reporting 
on equity in your reviews?
  
14. Are there any items missing from PRISMA-­E 2012?
  
*






  
Yes
  

No
  

Unsure
  

Additional  comments  


